INmune Bio, Inc. (NASDAQ:INMB) Short Interest Down 29.8% in August
MarketBeat
INmune Bio, Inc. (NASDAQ:INMB - Get Free Report) saw a significant decline in short interest in the month of August. As of August 31st, there was short interest totaling 3,740,000 shares, a decline of 29.8% from the August 15th total of 5,330,000 shares. Currently, 21.9% of the company's shares are short sold. Based on an average daily volume of 3,410,000 shares, the short-interest ratio is presently 1.1 days. Based on an average daily volume of 3,410,000 shares, the short-interest ratio is presently 1.1 days. Currently, 21.9% of the company's shares are short sold.
NASDAQ:INMB